Abstract
Rationale
Pediatric bipolar disorder (PBD) is a chronic and debilitating psychiatric illness. It is associated with many short-term and long-term complications including poor academic and social performance, legal problems and increased risk of suicide. Moreover, it is often complicated by other serious psychiatric disorders including attention deficit hyperactivity disorder, oppositional defiant disorder, conduct disorder and substance use disorders. For these reasons, there is a need for effective treatment for PBD.
Objectives
To review available data from published reports of the treatment of PBD, highlighting those treatment practices for which there is scientific evidence. To suggest directions for future research.
Materials and methods
A comprehensive Medline search was performed to identify published reports from 1995 to 2006. Reports with the greatest methodological stringency received greater focus.
Results
There is limited evidence from double-blind, placebo-controlled trials regarding the treatment of PBD. Available data suggests that lithium, some anticonvulsants and second-generation antipsychotics may be equally beneficial in the acute monotherapy for youth with mixed or manic states. However, because of limited response to acute monotherapy, there is increased justification for combination therapy. There is very limited data on the treatment of the depressed phase of bipolar illness in the youth. Also, very few studies have addressed the treatment of comorbidities and maintenance/relapse prevention in PBD.
Conclusion
Although significant progress was made in the treatment of youth with bipolar disorder, there is a need for more methodologically stringent research to more precisely define evidence-based treatment strategies for PBD.
Similar content being viewed by others
References
Altshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, Frye M, Gitlin M, Hwang S, Goodman R, Leverich G, Nolen W, Kupka R, Post R (1999) Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disord 1(1):61–65
Baldelssarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE Jr, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA Jr, Baker RW, Tohen M (2003) Olanzapine versus placebo in acute mania: treatment responses in subgroup. J Clin Psychopharmacol 23(4):370–376
Baker RW, Tohen M, Fawcett J, Risser RC, Schuh LM, Brown E, Stauffer VL, Shao L, Tollefson GD (2003) Acute dysphoric mania: treatment response to olanzepine versus placebo. J Clin Psychopharmacol 23(2):132–137
Barbini et al (1997) Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol 12(2):109–112
Barnett MS (2004) Ziprasidone monotherapy in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 14(3):471–477
Barzman DH, DelBello MP, Kowatch RA, Gernert B, Fleck DE, Pathak S, Rappaport K, Delgado SV, Campbell P, Strakowski SM (2004) The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacol 14(4):593–600
Benedetti A et al (2004) Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episodes. J Affect Disord 79(1–3):273–277
Biederman J, Mick E, Prince J, Bostic JQ, Wilens TE, Spencer T, Wozniak J, Faraone SV (1999) Systematic chart review of the pharmacological treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder. J Child Adolesc Psychopharmacol 9(4):247–256
Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV (2000) Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10(3):185–192
Biederman J, Mick E, Wozniak J, Aleardi M, Spencer T, Faraone SV (2005a) An open-label trial of risperidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 15(2):311–317
Biederman J, Mick E, Hammerness P, Harpold T, Aleardi M, Dougherty M, Wozniak J (2005b) Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 58(7):589–594
Biederman J, McDonnell MA, Wozniak J, Spencer T, Aleardi M, Falzone R, Mick E (2005c) Aripiprazole in the treatment of pediatric bipolar disorder: a systemic chart review. CNS Spectr 10(2):141–148
Blackburn IM, Loudon JB, Ashworth CM (1977) A new scale for measuring mania. Psychol Med 7(3):453–458
Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J, Lamictal 606 Study Group (2003) A placebo-controlled 18-month trial of lamotrigene and lithium maintenance treatment in recently manic or hypomanic patients with bipolar disorder. Arch Gen Psychiatry 60(4):392–400
Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagero M, Svensson K (2005) A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium monotherapy for mania in bipolar disorder. J Clin Psychiatry 66(1):111–121
Caffey EM Jr, Prien RF (1970) The VA-NIMH study of lithium in affective disorders. Psychosomatics 11(5):409–412
Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY (1996) Clozapine for treatment-refractory mania. Am J Psychiatry 153(6):759–764
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60(2):79–88
Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET (2000) A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61(11):841–850
Calabrese JR et al (2001) A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 21(3):340–342
Calabrese JR, Bowden CL, Sachs GS, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J, Lamictal 605 Study Group (2003) A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64(9):1013–1024
Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J (2005a) A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162(7):1351–1360
Calabrese JR, Shelton MD, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Ganocy SJ, Findling RL (2005b) A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 162(11):2152–2161
Carlson GA, Bromet EJ, Driessens C, Mojtabai R, Schwartz JE (2002) Age at onset, childhood psychopathology, and 2-year outcome in psychotic bipolar disorder. Am J Psychiatry 159(2):307–309
Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, Emslie G, Flynn L, Goodwin F, Hellander M, Kowatch R, Kusumakar V, Laughren T, Leibenluft E, McCracken J, Nottelmann E, Pine D, Sachs G, Shaffer D, Simar R, Strober M, Weller EB, Wozniak J, Youngstrom EA (2003) Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol 13(1):13–27
Carandang CG, Maxwell DJ, Robbins DR, Oesterheld JR (2003) Lamotrigine in adolescent mood disorders. J Am Acad Child Adolesc Psychiatry 42(7):750–751
Catapano-Friedman L (2001) Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis. J Child Adolesc Psychopharmacol 11(2):205–206
Cesena M, Gonzalez-Heydrich J, Szigethy E, Kohlenberg TM, DeMaso DR (2002) A case series of eight aggressive young children treated with risperidone. J Child Adolesc Psychopharmacol 12(4):337–345
Chang KD, Ketter TA (2000) Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adolesc Psychopharmacol 10(1):45–49
Chang K, Saxena K, Howe M (2006) An open-label study of lamotrigene adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45(3):298–304
Ciapparelli A, Dell’osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB (2000) Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry 61(5):329–334
Craven C, Murphy M (2000) Carbamazepine treatment of bipolar disorder in an adolescent with cerebral palsy. J Am Acad Child Adolesc Psychiatry 39(6):680–681
Davanzo P, Gunderson B, Berlin T, Mintz J, Pataki C, Ott D, Emley-Akanno C, Montazeri N, Oppenheimer J, Strober M (2003) Mood stabilizers in hospitalized children with bipolar disorder: a retrospective chart review. Psychiatry Clin Neurosci 57(5):504–510
Davanzo P, Nikore V, Yehya N, Stevenson L (2004) Oxcarbazepine treatment of juvenile-onset bipolar disorder. J Child Adolesc Psychopharmacol 14(3):344–345
DelBello MP, Kowatch RA, Warner J, Schwiers ML, Rappaport KB, Daniels JP, Foster KD, Strakowski SM (2002a) Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review. J Child Adolesc Psychopharmacol 12(4):323–330
DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM (2002b) A double-blind, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41(10):1216–1223
DelBello MP, Findling RL, Kushner S, Wang D, Olson WH, Capece JA, Fazzio L, Rosenthal NR (2005) A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44(6):539–547
DelBello MP, Kowatch RA, Adler CM, Stanford KE, Welge JA, Barzman DH, Nelson E, Strakowski SM (2006) A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 45(3):305–313
Durkin JP (2004) Aripiprazole in the treatment of bipolar disorder in children and adolescents. J Child Adolesc Psychopharmacol 14(4):505–506
Duval SJ (2005) Six-year old Thomas diagnosed with pediatric onset bipolar disorder: a case study. J Child Adolesc Psychiatr Nurs 18(1):38–42
Endicott J, Spitzer RL (1978) A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35(7):837–844
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J (1998) An open label study of gabapentin in the treatment of acute mania. J Psychiatr Res 32(5):261–264
Findling RL, Gracious BL, McNamara NK, Youngstrom EA, Demeter CA, Branicky LA, Calabrese JR (2001) Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 3(4):202–210
Findling RL, McNamara NK, Gracious BL, Youngstrom EA, Stansbrey RJ, Reed MD, Demeter CA, Branicky LA, Fisher KE, Calabrese JR (2003) Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 42(8):895–901
Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR (2005) Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44(5):409–417
Findling RL, McNamara NK, Stansbrey R, Gracious BL, Whipkey RE, Demeter CA, Reed MD, Youngstrom EA, Calabrese JR (2006) Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry 45(2):142–148
Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, Kim GS, Shapiro S (1999) Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 38(8):960–965
Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Riser RC, Nowlin ZM (2001) A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11(3) 239–250
Fuchs, DC (1994) Clozapine treatment of bipolar disorder in a young adolescent. J Am Acad Child Adolesc Psychiatry 33(9):1299–1302
Geller B, Luby J (1997) Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 36(9):1168–1176
Geller B, Cooper TB, Sun K, Zimmerman B, Frazier J, Williams M, Heath J (1998) Double-blind and placebo-controlled study of lithium for adolescent bipolar disorder with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 37(2):171-178
Geller B, Tillman R, Craney JL, Bolhofner K (2004) Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry 61(5):459–467
Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R (2004) A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65(3):432–441
Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C Jr, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF (2000) Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 157(6):982–986
Grunze HC, Normann C, Langosch J, Schaefer M, Amann B, Sterr A, Schloesser S, Kleindienst N, Walden J (2001) Antimanic efficacy of topiramate in 11 patients in an open trial with an on–off–on design. J Clin Psychiatry 62(6):464–468
Guy W (ed) (1976) ECDEU Assessment manual for psychopharmacology. US Department of Health, Education and Welfare Publication ADM 76-338, National Institute of Mental Health, Rockville, MD
Hirshfeld RM, Eardekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM (2006) An open-label extension trial of risperidone monotherapy in the treatment of bipolar disorder. Int Clin Psychopharmacol 21(1):11–20
Hummel B, Walden J, Stampfer R, Dittmann S, Amann B, Sterr A, Schaefer M, Frye MA, Grunze H (2002) Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on–off–on design. Bipolar Disord 4(6):412–417
Ichim L, Berks M, Brooks S (2000) Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 12(150):5–10
Kafantaris V (1995) Treatment of bipolar disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 34(6):732–734
Kafantaris V, Dicker R, Coletti DJ, Kane JM (2001a) Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania. J Child Adolesc Psychopharmacol 11(4):409–413
Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM (2001b) Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry 40(12):1448–1456
Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM (2003) Lithium treatment of acute mania in adolescents: a large open trial. J Am Acad Child Adolesc Psychiatry 42(9):1038–1045
Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JM (2004) Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 43(8):984–993
Kant R, Chalansani R, Chengappa KN et al (2004) The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder. J Child Adolesc Psychopharmacol 14(1):57–63
Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K, Ziprasidone in Mania Study Group (2003a) Ziprasidone in the treatment of acute bipolar mania; a three week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160(4):741–748
Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G, Aripiprazole Study Group (2003b) A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160(9):1651–1658
Keller B (2004) Improving the course of illness and promoting continuation of treatment of bipolar disorder. J Clin Psychiatry 65(Suppl 15):10–14
Ketter TA, Kalali AH, Weisler RH, SPD417 Study Group (2004) A multicenter, open-label evaluation of beaded, extended-release carbamazepine capsules as monotherapy in bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65(4):478–484
Khanna S, Vieta E, Lyons B et al (2005) Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 187:229–234
Kowatch RA, Suppes T, Gilfillan SK, Fuentes RM, Granneman BD, Emslie GJ (1995) Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: a clinical case series. J Child Adolesc Psychopharmacol 39:713–720
Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M, Emslie GJ, Weinberg WA, Rush AJ (2000) Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 39(6):713–720
Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA (2003) Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 53(11):978–984
Kowatch RA, DelBello MP (2005) Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr Clin North Am 28(2):385–397
Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M, Child Psychiatry Workgroup on Bipolar Disorder (2005) Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44(3):213–235
Krishnamoorthy J, King BH (1998) open-label olanzapine trial in five preadolescent children. J Child Adolesc Psychopharmacol 8(2):107–113
Marchand WR, Wirth L, Simon C (2004) Quetiapine adjunctive and monotherapy for pediatric bipolar disorder; a retrospective chart review. J Child Adolesc Psychopharmacol 14(3):405–411
Masi G, Milone A (1998) Clozapine treatment in an adolescent with bipolar disorder. Panminerva Med 40(3):254–257
Masi G, Mucci M, Millepiedi S (2002) Clozapine in adolescent inpatient mania. J Child Adolesc Psychopharmacol 12(2):93–99
McElroy SL, Keck PE Jr (2000) Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 48(6):539–557
McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J (2004) A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. J Clin Psychiatry 65(2):204–210
Muzina DJ, Calabrese JR (2005) Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust NZJ Psychiatry 39(8):652–661
Myers WC, Carrera F III (1989) Carbamazepine-induced mania with hypersexuality in a 9-year-old boy. Am J Psychiatry 146(3):400
Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G (2000) Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2(3 pt 2):249–255
Papatheodorou G, Kutcher SP, Katic M, Szalai JP (1995) The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol 15(2):110–116
Patel NC, DelBello MP, Bryan HS, Adler CM, Kowatch RA, Stanford K, Strakowski SM (2006) Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45(3):289–297
Pavuluri MN, Janicak PG, Carbray J (2002) Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania. J Child Adolesc Psychopharmacol 12(3):271–273
Pavuluri MN, Henry DB, Carbray JA et al (2004) Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J Affect Disord 82(Suppl 1):S103–S111
Pavuluri MN, Birmaher B, Naylor MW (2005) Pediatric bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 44(9):846–871
Potkin SG, Keck PE Jr, Segal S, Ice K, English P (2005) Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 25(40):301–310
Power PS, Sachs GS, Kushner SF et al (2004) Topiramate in adults with acute bipolar I mania. Posted results, presented at the 157th Annual Meeting of the American Psychiatric Association, New York
Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R (1984) Preliminary studies of the reliability and validity of the children’s depression rating scale. J Am Acad Child Psychiatry 23(2):191–197
Poznanski EO, Freeman LN, Mokros HB (1985) Children’s depression rating scale-revised. Psychopharmacology Bull 21:979–989
Prien RF, Caffey EM Jr, Klett CJ (1972) Comparism of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veteran Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 26(2):146–153
Rajeev J, Srinath S, Girimaji S, Seshadri SP, Singh P (2004) A systematic chart review of the naturalistic course and treatment of early-onset bipolar disorder in a child and adolescent psychiatry center. Compr Psychiatry 45(2):148–154
Reiss AL, O’Donnell DJ (1984) Carbamazepine-induced mania in two children: case report. J Clin Psychiatry 45(6):272–274
Schaller JL, Behar D (1999) Quetiapine for refractory mania in a child. J Am Acad Child Adolesc Psychiatry 38(5):498–499
Scheffer RE, Kowatch RA, Carmody T, Rush AJ (2005) Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162(1):58–64
Schreier HA (1998) Risperidone for young children with mood disorder and aggressive behavior. J Child Adolesc Psychopharmacol 8(1):49–59
Shaffer D et al (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40(11):1228–1231
Smulevich AB, Khanna S, Eerdekens M, Karcher K, Kramer M, Grossman F (2005) Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur Neuropsychopharmacol 15(1):75–84
Soutullo CA, Casuto LS, Keck PE Jr (1998) Gabapentin in the treatment of adolescent mania: a case report. J Child Adolesc Psychopharmacol 8(1):81–85
Soutullo CA, Sorter MT, Foster KD, McElroy SL, Keck PE (1999) Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affect Disord 53(3):279–283
State RC, Frye MA, Altshuler LL, Strober M, DeAntonio M, Hwang S, Mintz J (2004) Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. J Clin Psychiatry 65(8):1057–1063
Strober M, DeAntonio M, Schmidt-Lackner S, Freeman R, Lampert C, Diamond J (1998) Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescents. J Affect Disord 51(2):145–151
Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156(8):1164–1169
Suppes T, Ozcan ME, Carmody T (2004) Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord 694:329–332
Suppes T, Dennehy EB, Hirshfeld RM, Altshuler LL, Bowden CL, Calabrese JR, Crismon ML, Ketter TA, Sachs GS, Swann AC, Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder (2005) The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 66(7):870–886
Teiltelbaum M (2001) Oxcarbazepine in bipolar disorder. J Am Acad Child Adolesc Psychiatry 40(9):993–994
Thakur A, Jagadheesan K, Sinha VK (2005) Lamotrigine add-on to valproate therapy for pediatric bipolar affective disorder. Aust N Z J Psychiatry 39(7):639
Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57(9):841–849, Erratum in: Arch Gen Psychiatry 59(1):91
Tohen M, Kryzhanovskaya L, Carlson G, DelBello MP, Wozniak J, Kowatch RA, Wagner K, Findling RL, Lin D, Robertson-Plouch C, Xu Wen, Huang Xiaohong, Dittmann R, Biederman J (2005) Olanzapine in the treatment of acute manic and mixed episodes in adolescents: a 3-week randomized double-blind placebo-controlled study. 44th American College of Neuropsychopharmacology, Waikoloa, Hawaii, Dec 11–15 2005
Vieta E, Martinez-Aran A, Nieto E, Colom F, Reinares M, Benabarre A, Gasto C (2000) Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 15(7):433–437
Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Swanink R, Iwamoto T, on behalf of The Aripiprazole Study Group (2005) Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomized comparative 12-week trial. Br J Psychiatry 187:235–242
Wagner KD, Weller EB, Carlson GA, Sachs G, Biederman J, Frazier JA, Wozniak P, Tracy K, Weller RA, Bowden C (2002) An open-trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 41(10):1224–1230
Wagner KD, Kowatch RA, Findling RL, Lehman RB, Berv D, Linden D, McCague (2005) Oxcarbazepine in the treatment of children with bipolar disorder: a multicenter, double-blind, placebo-controlled trial. American Academy of Child and Adolescent Psychiatry, Toronto, Canada, Oct 18–23
Weisler RH, Kalali AH, Ketter TA; SPD417 Study Group (2004) A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65(4):478–484
Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH; SP417 study group (2005) Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 66(3):323–330
Wilens TE, Biederman J, Forkner P, Ditterline J, Morris M, Moore H, Galdo M, Spencer TJ, Wozniak J (2003) Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. J Child Adolesc Psychopharmacol 13(4):495–505
Wilens TE, Biederman J, Kwon A, Ditterline J, Forkner P, Moore H, Swezey A, Snyder L, Henin A, Wozniak J, Faraone SV (2004) Risk of substance use disorders in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 43(11):1380–1386
Woolston JL (1999) Case study: carbamazepine treatment of juvenile-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 38(3):335–338
Wozniak J, Biederman J, Kiely K, Ablon JS, Faraone SV, Mundy E, Mennin D (1995) Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry 34(7):867–876
Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Smarty, S., Findling, R.L. Psychopharmacology of pediatric bipolar disorder: a review. Psychopharmacology 191, 39–54 (2007). https://doi.org/10.1007/s00213-006-0569-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-006-0569-y